API Intermediate Market to Increase Steadily by 2017-2023
Rise in adoption of generic drugs, speciality medicine, surge in demand for biopharmaceuticals, and increase in abbreviated new drug applications drive the API Intermediate Market. Furthermore, rise in incidence of diseases and growth in geriatric population prone to various diseases and disorders are anticipated to lead to market growth. R&D activities on development and improvement of drugs for chronic diseases and FDA approvals for new molecules present new opportunities for market expansion. However, stringent government regulations are expected to hinder...
View full press release